《MICROBES INFECT,2月4日,Pathogenicity and Transmissibility of 2019-nCoV—A Quick Overview and Comparison with Other Emerging Viruses》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2020-02-08
  • Pathogenicity and Transmissibility of 2019-nCoV—A Quick Overview and Comparison with Other Emerging Viruses

    Author links open overlay panelJieliangChenM.D., Ph.D.

    https://doi.org/10.1016/j.micinf.2020.01.004

    Abstract

    A zoonotic coronavirus, labeled as 2019-nCoV by The World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted.

  • 原文来源:https://sciencedirect.xilesou.top/science/article/pii/S1286457920300265
相关报告
  • 《Microbes Infect , 2月4日,Pathogenicity and Transmissibility of 2019-nCoV-A Quick Overview and Comparison With Other Emerging Viruses》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-02-09
    • Pathogenicity and Transmissibility of 2019-nCoV-A Quick Overview and Comparison With Other Emerging Viruses Jieliang Chen 1 PMID: 32032682 DOI: 10.1016/j.micinf.2020.01.004 Abstract A zoonotic coronavirus, labeled as 2019-nCoV by The World Health Organization (WHO), has been identified as the causative agent of the viral pneumonia outbreak in Wuhan, China, at the end of 2019. Although 2019-nCoV can cause a severe respiratory illness like SARS and MERS, evidence from clinics suggested that 2019-nCoV is generally less pathogenic than SARS-CoV, and much less than MERS-CoV. The transmissibility of 2019-nCoV is still debated and needs to be further assessed. To avoid the 2019-nCoV outbreak turning into an epidemic or even a pandemic and to minimize the mortality rate, China activated emergency response procedures, but much remains to be learned about the features of the virus to refine the risk assessment and response. Here, the current knowledge in 2019-nCoV pathogenicity and transmissibility is summarized in comparison with several commonly known emerging viruses, and information urgently needed for a better control of the disease is highlighted.
  • 《SSRN,2月13日,Novel Coronavirus (2019-nCoV) Outbreak; A Systematic Review for Published Papers》

    • 来源专题:COVID-19科研动态监测
    • 编译者:xuwenwhlib
    • 发布时间:2020-02-14
    • Novel Coronavirus (2019-nCoV) Outbreak; A Systematic Review for Published Papers 23 Pages Posted: 13 Feb 2020 Adel Al-Gheethi Universiti Tun Hussein Onn Malaysia (UTHM) - Micropollutant Research Centre (MPRC) Efaq Noman Taiz University - Department of Applied Microbiology Qais Ali Al-Maqtari Jiangnan University - State Key Laboratory of Food Science and Technology Kamal Hezam Taiz University - Department of Applied Microbiology Radin Mohamed Universiti Tun Hussein Onn Malaysia (UTHM) - Micropollutant Research Centre (MPRC) Balkis Talip Universiti Tun Hussein Onn Malaysia (UTHM) - Faculty of Applied Sciences and Technology Norli Ismail Universiti Sains Malaysia (USM) - Environmental Technology Division Abstract The novel coronavirus (2019-nCoV) outbreak has been traced in China late 2019 and then was transmitted into more than 25 countries. A total of 49 papers have been published in 20 journals during the last January and current February. These papers tried to explain the source of virus, the transmission route, genomic map and the similarity to previous viruses as well as the pathogenesis, symptoms and treatment methods. The huge numbers of the articles which were published on 2019-nCoV make confusing for the readers, since many of the articles are addressed similar topics. In this paper a systematic analysis was conducted for the published articles. The finding of these papers were summarized. Moreover, the present paper aim to highlight the responses of scientists and Journals for the 2019-nCoV outbreak. This paper reviewed 49 peer viewed articles while hundreds article still in the preprint. It was appeared that the Lancet journal has the highest numbers of publications (29%) which given an early alarm for 2019-nCoV. The first paper suggested Baricitinib as potential treatment for 2019-nCoV acute respiratory disease was published on 3 February in the Lancet Journal. In 16 January 2020, the genomic characteristics of the virus was published, followed by several papers on the diagnostic of the virus, pathogenicity and symptoms was more clear on 29 January. The Nature Journal was the fist which given an alarm for the 2019-nCoV outbreak. In conclusion source of 2019-nCoV, treatment methods, as well as vaccines, pathogenicity of the virus in the patient with HIV or other virus infections, transmission to fetus in the pregnant women still need more investigation.